Beta-blocker use and risk of acute exacerbations of COPD following first-time myocardial infarction. A Danish nationwide cohort study. Source: International Congress 2019 – More and more COPD Year: 2019
High coincidence of COPD with increased mortality in an unselected group of Danish patients with acute myocardial infarction Source: Eur Respir J 2005; 26: Suppl. 49, 218s Year: 2005
Beta-blocker, aspirin and statin usage after myocardial infarction in patients with and without COPD. A nationwide analysis from 1995 to 2015 in Denmark Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings Year: 2018
Myocardial infarction, heart failure and mortality in patients with COPD in primary care. Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
The prevalence of COPD in patients participated in rehabilitation program after myocardial infarction Source: Annual Congress 2013 –COPD mechanisms Year: 2013
COPD in patients evaluated for stable myocardial ischemia – observational study Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018
Overuse of short-acting ß2 -agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme Source: Eur Respir J, 55 (4) 1901872; 10.1183/13993003.01872-2019 Year: 2020
Risk of stroke in COPD: a matched cohort study Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function Year: 2017
Pattern of risk of myocardial infarction (MI) in patients taking asthma medication: a study with the UK general practice research database (GPRD) Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009
Non-aponea sleep disorder increases the risk of incident heart failure - a nationwide population-based cohort study Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities Year: 2018
Association between lung function and future risks of diabetes, asthma, myocardial infarction, hypertension and all-cause mortality Source: ERJ Open Res, 7 (3) 00178-2021; 10.1183/23120541.00178-2021 Year: 2021
Mortality and acute exacerbation of COPD: a pilot study on the influence of myocardial injury Source: Eur Respir J, 49 (6) 1700096; 10.1183/13993003.00096-2017 Year: 2017
Use of heart failure medications in outpatients with COPD and congestive heart failure: a Danish nationwide cohort study Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017
Passive smoking and risk of fatal and non-fatal myocardial infarction in a cohort of Danish workers Source: Annual Congress 2008 - Environmental tobacco smoke and smoking ban Year: 2008
Relationship between supernormal lung function and long-term risk of hospitalisations and mortality: a population-based cohort study Source: Eur Respir J, 57 (4) 2004055; 10.1183/13993003.04055-2020 Year: 2021
Acute myocardial infarction in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
Respiratory function in chronic stroke patients: an observational study. Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions Year: 2021
Survival after intensive care for COPD exacerbation in patients with and without long-term oxygen therapy: a nationwide cohort study Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure Year: 2019
Increased mortality in patients with corticosteroid-dependent asthma: a nationwide population-based study Source: Eur Respir J, 54 (5) 1900804; 10.1183/13993003.00804-2019 Year: 2019
Clinical examination and all-cause mortality in non-mild COPD population – prospective study Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019